Why These Two Gene-Editing Stocks Just Surged - Investor's Business Daily

1. Why These Two Gene-Editing Stocks Just Surged  Investor's Business Daily
2. CRISPR gene-editing works to reduce high cholesterol in a new study  NPR
3. Harmful cholesterol levels cut in half with one-time gene editing drug in early trial  NBC News
4. Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides  Cleveland Clinic Newsroom
5. Manage heart disease without pills or diet? Single treatment to cut bad cholesterol in half  Times of India

from Top stories - Google News https://ift.tt/gzIvTtk